NARI - יחס חוב להיוון בספרים Inari Medical Inc

Inari Medical, Inc. (NARI) generates revenue from the supply of FlowTriever and ClotTriever systems for mechanical thrombectomy. Its primary customers are radiologists and clinics that utilize catheters for safe vascular treatment. The history of the total debt-to-equity ratio demonstrates financial stability, with the value maintained at 0.08. However, competitive pressure and pricing demands from hospital networks remain key risk factors.

Inari Medical, Inc. (NARI) demonstrates high financial resilience driven by stable demand for venous procedure systems. The debt-to-book capitalization ratio measures the proportion of borrowed capital relative to equity, determining the level of financial leverage. A decrease in this metric indicates a minimization of credit risks and independence from external loans. Predictable cash flows allow the company to effectively optimize its liability structure. Such a strategy strengthens the fundamental margin of safety and supports the long-term stability of share prices.